These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 14379010)

  • 1. The relative immunizing efficiency of tetanus toxoid preparations.
    GREENBERG L
    Bull World Health Organ; 1955; 12(5):761-8. PubMed ID: 14379010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relative immunizing efficiency of diphtheria toxoid preparations.
    GREENBERG L
    Bull World Health Organ; 1955; 12(5):751-60. PubMed ID: 14379009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Collaborative study for the validation of alternative in vitro potency assays for human tetanus immunoglobulin.
    Gross S; Janssen SW; de Vries B; Terao E; Daas A; Buchheit KH
    Pharmeur Bio Sci Notes; 2009 Oct; 2009(1):11-25. PubMed ID: 20144449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. International standard for tetanus toxoid.
    GREENBERG L
    Bull World Health Organ; 1953; 9(6):837-42. PubMed ID: 13141135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunization against neonatal tetanus in New Guinea. 5. Laboratory assayed potency of tetanus toxoids and relationship to human antitoxin response.
    Pittman M; Kolb RW; Barile MF; Hardegree MC; Seligmann EB; Maclennan R; Schofield FD
    Bull World Health Organ; 1970; 43(3):469-78. PubMed ID: 5313001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. International collaborative studies on potency assays of diphtheria and tetanus toxoids.
    Van Ramshorst JD; Sundaresan TK; Outschoorn AS
    Bull World Health Organ; 1972; 46(2):263-76. PubMed ID: 4537488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance and potency of tetanus toxoid: implications for eliminating neonatal tetanus.
    Dietz V; Milstien JB; van Loon F; Cochi S; Bennett J
    Bull World Health Organ; 1996; 74(6):619-28. PubMed ID: 9060223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Collaborative study for the establishment of tetanus vaccine (adsorbed) Third International Standard and European Pharmacopoeia Biological Reference Preparation batch no. 2.
    Sesardic D; Winsnes R; Rigsby P; Gaines-Das R
    Pharmeuropa Spec Issue Biol; 2001 Aug; 2001(1):45-72. PubMed ID: 11705100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The serological assessment of a tetanus toxoid field trial.
    Newell KW; Leblanc DR; Edsall G; Levine L; Christensen H; Montouri MH; Ramirez N
    Bull World Health Organ; 1971; 45(6):773-85. PubMed ID: 4947832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Collaborative study for the establishment of two European Pharmacopoeia Biological Reference Preparations for serological potency testing of tetanus vaccines for veterinary use.
    Lensing HH; Behr-Gross ME; Daas A; Spieser JM
    Dev Biol (Basel); 2002; 111():69-76. PubMed ID: 12678226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunization against neonatal tetanus in New Guinea.
    Hardegree MC; Barile MF; Pittman M; Schofield FD; Maclennan R; Kelly A
    Bull World Health Organ; 1970; 43(3):439-51. PubMed ID: 5312998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potency assay of diphtheria and tetanus toxoids some theoretical and practical considerations.
    Lyng J
    Dev Biol Stand; 1986; 64():47-50. PubMed ID: 3792657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The differences in immunizing capacity between various tetanus toxoids in active-passive immunization with human antitoxin.
    Cohen H; Peetoom F; van Ramshorst JD
    Prog Immunobiol Stand; 1970; 4():527-32. PubMed ID: 5482197
    [No Abstract]   [Full Text] [Related]  

  • 14. Serological methods for potency testing of tetanus toxoid vaccines for human use.
    Hendriksen C; Winsnes R
    Dev Biol (Basel); 2002; 111():131-40. PubMed ID: 12678232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Active immunization against tetanus III. Results of a five year study.
    Mya MM; To M; Sein SM; Win MT
    Southeast Asian J Trop Med Public Health; 1980 Dec; 11(4):543-6. PubMed ID: 6452697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of a three-component acellular pertussis vaccine with a whole-cell pertussis vaccine in 15- through 20-month-old infants.
    Bernstein HH; Rothstein EP; Reisinger KS; Blatter MM; Arbeter AM; Fontana ME; Jacobs JM; Long SS; Rathfon H; Crayne O
    Pediatrics; 1994 Apr; 93(4):656-9. PubMed ID: 8134224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The simultaneous use of serum and toxoid in tetanus prophylaxis].
    ECKMANN L
    Schweiz Med Wochenschr; 1959 Mar; 89():311-5. PubMed ID: 13819240
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies on the adequate composition of diphtheria and tetanus toxoids-with reference to the amounts of toxoids and aluminum adjuvant.
    Someya S; Mizuhara H; Murata R; Kurokawa M
    Jpn J Med Sci Biol; 1981 Feb; 34(1):21-35. PubMed ID: 7265558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunization against neonatal tetanus in New Guinea. 3. The toxin-neutralization test and the response of guinea-pigs to the toxoids as used in the immunization schedules in New Guinea.
    Barile MF; Hardegree MC; Pittman M
    Bull World Health Organ; 1970; 43(3):453-9. PubMed ID: 5312999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Collaborative assay of a proposed international standard for tetanus toxoid (adsorbed).
    van Ramshorst JD; Sundaresan TK
    Bull World Health Organ; 1972; 46(1):53-66. PubMed ID: 4537335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.